Heparin ameliorates brain injury by inhibiting leukocyte accumulation.
Yanaka
K
K
Nose
T
T
D000925:Anticoagulants / Q000494:pharmacology* / Q000627:therapeutic use; D001930:Brain Injuries / Q000150:complications* / Q000503:physiopathology; D002448:Cell Adhesion / Q000187:drug effects; D006493:Heparin / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D007962:Leukocytes / Q000187:drug effects*; D013997:Time Factors; D016896:Treatment Outcome
D000925:Anticoagulants; D006493:Heparin